A recent study discovered that population-based genomic screening can help in the early diagnosis of medullary thyroid cancer (MTC) in patients with RET gene variations.
Population-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene, a new Geisinger study found.